MYCN amplification is the most common genetic aberration associated with poor prognosis in neuroblastoma (NB) [1, 2, 3] and is identified as the primary driver in a rare and aggressive subtype of retinoblastoma (RB) [4, 5]. Here, MYCN is linked to neuroblastoma.